Gapping up
In reaction to strong earnings/guidance: MLNX +3%, CAFD +1.3%, USAT +0.5%
M&A news: TEVA +2.3% (will acquire Mexican pharma Rimsa for $2.3 bln; accretive to non-GAAP earnings starting in 1Q17), .
Select oil/gas related names showing strength: PTEN +4.1%, SDRL +2.5%, BP +2.3%, TOT +2.3%, RDS.A +2.3%, STO +2.3%, LINE +2.2%, RIG +1.8%, KMI +1.2%
Other news: XOMA +54.3% (has exclusively licensed the global development and commercialization rights, to its growth factor-beta antibody program to Novartis (NVS)), SRPT +17.4% (announces additional long-term efficacy and safety data from pivotal Phase IIb program of Eteplirsen), VRSK +5.5% (to replace JOYG in the S&P 500), PBF +5% (PBF Energy announces purchase of 155,000 barrel-per-day Torrance refinery and related logistics assets from ExxonMobil (XOM) for $537.5 mln), HUN +3.2% (authorization of a $150 mln repurchase program), IMAX +2.1% (announces the pricing of its IMAX China IPO; expects to receive proceeds of $85.7 mln), DDR +2.1% (reports the disposition of 21 assets totaling $302 million, during the third quarter of 2015), AVP +1.5% (still checking), HL +1.5% (increases stake in Dolly Varden Silver), PRGO +1.4% (in symp with TEVA), AYA +1.4% (receives authorization from the New Jersey Division of Gaming Enforcement to operate the PokerStars and Full Tilt brands in New Jersey ), FCAU +1.1% (September US sales rise 14%), MAC +1% announced $1.2 bln share repurchase program), MYL +1% (in symp with TEVA)
Analyst comments: SGYP +7.5% (initiated with a Buy at H.C. Wainwright; tgt $20), JD +2.6% (upgraded to Buy from Hold at Deutsche Bank), SNDK +1.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley), CELG +1.4% (upgraded to Overweight from Neutral at JP Morgan), DVN +1.3% (upgraded to Outperform at Bernstein)
In reaction to strong earnings/guidance: MLNX +3%, CAFD +1.3%, USAT +0.5%
M&A news: TEVA +2.3% (will acquire Mexican pharma Rimsa for $2.3 bln; accretive to non-GAAP earnings starting in 1Q17), .
Select oil/gas related names showing strength: PTEN +4.1%, SDRL +2.5%, BP +2.3%, TOT +2.3%, RDS.A +2.3%, STO +2.3%, LINE +2.2%, RIG +1.8%, KMI +1.2%
Other news: XOMA +54.3% (has exclusively licensed the global development and commercialization rights, to its growth factor-beta antibody program to Novartis (NVS)), SRPT +17.4% (announces additional long-term efficacy and safety data from pivotal Phase IIb program of Eteplirsen), VRSK +5.5% (to replace JOYG in the S&P 500), PBF +5% (PBF Energy announces purchase of 155,000 barrel-per-day Torrance refinery and related logistics assets from ExxonMobil (XOM) for $537.5 mln), HUN +3.2% (authorization of a $150 mln repurchase program), IMAX +2.1% (announces the pricing of its IMAX China IPO; expects to receive proceeds of $85.7 mln), DDR +2.1% (reports the disposition of 21 assets totaling $302 million, during the third quarter of 2015), AVP +1.5% (still checking), HL +1.5% (increases stake in Dolly Varden Silver), PRGO +1.4% (in symp with TEVA), AYA +1.4% (receives authorization from the New Jersey Division of Gaming Enforcement to operate the PokerStars and Full Tilt brands in New Jersey ), FCAU +1.1% (September US sales rise 14%), MAC +1% announced $1.2 bln share repurchase program), MYL +1% (in symp with TEVA)
Analyst comments: SGYP +7.5% (initiated with a Buy at H.C. Wainwright; tgt $20), JD +2.6% (upgraded to Buy from Hold at Deutsche Bank), SNDK +1.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley), CELG +1.4% (upgraded to Overweight from Neutral at JP Morgan), DVN +1.3% (upgraded to Outperform at Bernstein)